A detailed history of State Street Corp transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, State Street Corp holds 3,183,542 shares of PTGX stock, worth $125 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,183,542
Previous 2,082,324 52.88%
Holding current value
$125 Million
Previous $72.2 Million 98.29%
% of portfolio
0.01%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$33.72 - $47.33 $37.1 Million - $52.1 Million
1,101,218 Added 52.88%
3,183,542 $143 Million
Q2 2024

Aug 14, 2024

SELL
$24.66 - $34.8 $29.3 Million - $41.4 Million
-1,190,161 Reduced 36.37%
2,082,324 $72.2 Million
Q1 2024

May 15, 2024

BUY
$21.79 - $32.15 $11.8 Million - $17.4 Million
542,556 Added 19.87%
3,272,485 $94.7 Million
Q4 2023

Feb 14, 2024

SELL
$14.05 - $23.44 $17 Million - $28.4 Million
-1,212,209 Reduced 30.75%
2,729,929 $62.6 Million
Q3 2023

Nov 14, 2023

BUY
$16.68 - $23.66 $6.51 Million - $9.23 Million
390,152 Added 10.98%
3,942,138 $65.8 Million
Q2 2023

Aug 14, 2023

BUY
$18.02 - $29.36 $20.5 Million - $33.4 Million
1,138,285 Added 47.16%
3,551,986 $98.1 Million
Q1 2023

May 15, 2023

SELL
$10.78 - $25.38 $14.9 Million - $35 Million
-1,379,225 Reduced 36.36%
2,413,701 $55.5 Million
Q4 2022

Feb 14, 2023

SELL
$7.36 - $11.17 $6.5 Million - $9.87 Million
-883,756 Reduced 18.9%
3,792,926 $41.4 Million
Q3 2022

Nov 15, 2022

SELL
$7.86 - $11.71 $16.5 Million - $24.6 Million
-2,099,587 Reduced 30.98%
4,676,682 $39.4 Million
Q2 2022

Aug 15, 2022

BUY
$7.06 - $25.52 $24.8 Million - $89.8 Million
3,519,461 Added 108.06%
6,776,269 $53.6 Million
Q1 2022

May 16, 2022

BUY
$23.34 - $36.08 $16 Million - $24.7 Million
685,238 Added 26.65%
3,256,808 $77.1 Million
Q4 2021

Feb 14, 2022

BUY
$17.63 - $37.1 $9.83 Million - $20.7 Million
557,591 Added 27.69%
2,571,570 $87.9 Million
Q3 2021

Nov 15, 2021

BUY
$12.95 - $49.69 $7.24 Million - $27.8 Million
559,359 Added 38.45%
2,013,979 $35.7 Million
Q2 2021

Aug 16, 2021

SELL
$25.57 - $44.88 $6.6 Million - $11.6 Million
-258,063 Reduced 15.07%
1,454,620 $65.3 Million
Q1 2021

May 17, 2021

BUY
$19.02 - $31.15 $4.34 Million - $7.11 Million
228,367 Added 15.39%
1,712,683 $44.4 Million
Q4 2020

Feb 16, 2021

BUY
$18.49 - $25.13 $6.1 Million - $8.29 Million
329,763 Added 28.56%
1,484,316 $29.9 Million
Q3 2020

Nov 10, 2020

BUY
$15.19 - $22.4 $11.7 Million - $17.3 Million
771,659 Added 201.53%
1,154,553 $22.6 Million
Q2 2020

Aug 14, 2020

BUY
$6.19 - $18.84 $402,981 - $1.23 Million
65,102 Added 20.49%
382,894 $6.76 Million
Q1 2020

May 11, 2020

BUY
$5.4 - $9.22 $1.72 Million - $2.93 Million
317,792 New
317,792 $2.24 Million

Others Institutions Holding PTGX

About Protagonist Therapeutics, Inc


  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $1.93B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.